Medicine
Methotrexate 2.5 mg tablet
Methotrexate 2.5 mg tablet is a generic prescription medicine for oral use, made by 22 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Methotrexate
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 36 tablets, 500 tablets and 72 more
- Manufacturers
- Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaAurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaAccord HealthcareIndiaBryant Ranch PrepackTeva PharmaceuticalsChartwell RXElite LaboratoriesHikma Pharmaceuticals22 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01BA01 Methotrexate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 November 1990
- Identifiers
- RxCUI 105585DailyMed set ID 4a04756f-e1c9-4d1e-b309-7be31c9176d6, 9b34b1d8-d125-41a2-9f6f-3fab67b573bd, 874c7f43-a3be-4236-89cc-24c44e3c5813 +27NDC 72162-2647, 0555-0572, 16729-486 +27Application ANDA217552, ANDA081099, ANDA213343 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 22 labelers. The register lists 75 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 46708-730-31 | Alembic PharmaceuticalsIndia | 4 June 2024 |
| 36 tablet in 1 bottle | 46708-730-36 | Alembic PharmaceuticalsIndia | 4 June 2024 |
| 100 tablet in 1 bottle | 62332-730-31 | Alembic PharmaceuticalsIndia | 4 June 2024 |
| 36 tablet in 1 bottle | 62332-730-36 | Alembic PharmaceuticalsIndia | 4 June 2024 |
| 100 tablet in 1 bottle | 68382-775-01 | Zydus LifesciencesIndia | 9 February 2017 |
| 500 tablet in 1 bottle | 68382-775-05 | Zydus LifesciencesIndia | 9 February 2017 |
| 1000 tablet in 1 bottle | 68382-775-10 | Zydus LifesciencesIndia | 9 February 2017 |
| 90 tablet in 1 bottle | 68382-775-16 | Zydus LifesciencesIndia | 9 February 2017 |
| 36 tablet in 1 bottle | 68382-775-60 | Zydus LifesciencesIndia | 9 February 2017 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 68382-775-77 | Zydus LifesciencesIndia | 9 February 2017 |
| 1000 tablet in 1 bottle | 70771-1058-0 | Zydus LifesciencesIndia | 9 February 2017 |
| 100 tablet in 1 bottle | 70771-1058-1 | Zydus LifesciencesIndia | 9 February 2017 |
| 36 tablet in 1 bottle | 70771-1058-3 | Zydus LifesciencesIndia | 9 February 2017 |
| 500 tablet in 1 bottle | 70771-1058-5 | Zydus LifesciencesIndia | 9 February 2017 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 70771-1058-7 | Zydus LifesciencesIndia | 9 February 2017 |
| 90 tablet in 1 bottle | 70771-1058-9 | Zydus LifesciencesIndia | 9 February 2017 |
| 100 tablet in 1 bottle | 16729-486-01 | Accord HealthcareIndia | 24 August 2020 |
| 100 tablet in 1 bottle | 59651-182-01 | Aurobindo PharmaIndia | 30 January 2020 |
| 36 tablet in 1 bottle | 59651-182-36 | Aurobindo PharmaIndia | 30 January 2020 |
| 100 tablet in 1 bottle | 47335-235-83 | Sun Pharmaceutical IndustriesIndia | 10 November 2017 |
| 36 tablet in 1 bottle | 47335-235-96 | Sun Pharmaceutical IndustriesIndia | 10 November 2017 |
| 36 tablet in 1 bottle | 62135-772-35 | Chartwell RX | 29 August 2023 |
| 100 tablet in 1 bottle, plastic | 64850-330-01 | Elite Laboratories | 16 May 2024 |
| 100 tablet in 1 bottle, plastic | 0054-4550-25 | Hikma Pharmaceuticals | 1 August 1994 |
| 20 blister pack in 1 carton / 1 tablet in 1 blister pack | 51079-670-05 | Mylan Institutional | 13 July 1995 |
| 100 tablet in 1 bottle, plastic | 0378-0014-01 | Mylan Pharmaceuticals | 18 May 1992 |
| 100 tablet in 1 bottle | 0555-0572-02 | Teva Pharmaceuticals | 1 November 1990 |
| 36 tablet in 1 bottle | 0555-0572-35 | Teva Pharmaceuticals | 1 November 1990 |
| 30 tablet in 1 bottle | 71335-0782-1 | Bryant Ranch Prepack | 25 February 2019 |
| 12 tablet in 1 bottle | 71335-0782-2 | Bryant Ranch Prepack | 9 April 2021 |
| 20 tablet in 1 bottle | 71335-0782-3 | Bryant Ranch Prepack | 9 April 2021 |
| 100 tablet in 1 bottle | 71335-0782-4 | Bryant Ranch Prepack | 19 April 2018 |
| 36 tablet in 1 bottle | 71335-0782-5 | Bryant Ranch Prepack | 9 April 2021 |
| 24 tablet in 1 bottle | 71335-0782-6 | Bryant Ranch Prepack | 9 April 2021 |
| 90 tablet in 1 bottle | 71335-0782-7 | Bryant Ranch Prepack | 9 April 2021 |
| 4 tablet in 1 bottle | 71335-0782-8 | Bryant Ranch Prepack | 9 April 2021 |
| 30 tablet in 1 bottle | 71335-1118-1 | Bryant Ranch Prepack | 25 February 2019 |
| 12 tablet in 1 bottle | 71335-1118-2 | Bryant Ranch Prepack | 17 May 2024 |
| 20 tablet in 1 bottle | 71335-1118-3 | Bryant Ranch Prepack | 17 May 2024 |
| 100 tablet in 1 bottle | 71335-1118-4 | Bryant Ranch Prepack | 17 May 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methotrexate
Clinical summary
Methotrexate is a folate analog metabolic inhibitor indicated for neoplastic diseases for the, among other approved uses. It is available as injection, tablets and powder for injection for oral, subcutaneous and intramuscular use. MedsAcross supplies Methotrexate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethotrexateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Methotrexate prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
- Jylamvo: European public assessment report (EPAR) · European Medicines Agency
- Nordimet: European public assessment report (EPAR) · European Medicines Agency
Need Methotrexate 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.